- Report
- November 2024
- 400 Pages
Global
From €3660EUR$3,995USD£3,110GBP
- Report
- November 2024
- 750 Pages
Global
From €3660EUR$3,995USD£3,110GBP
- Report
- November 2024
- 300 Pages
Global
From €3660EUR$3,995USD£3,110GBP
- Report
- November 2024
- 700 Pages
Global
From €3660EUR$3,995USD£3,110GBP
- Report
- November 2024
- 200 Pages
Global
From €3660EUR$3,995USD£3,110GBP
- Report
- August 2024
- 80 Pages
Global
From €1374EUR$1,500USD£1,168GBP
- Report
- November 2024
- 350 Pages
Global
From €3660EUR$3,995USD£3,110GBP
- Report
- November 2024
- 350 Pages
Global
From €3660EUR$3,995USD£3,110GBP
- Report
- November 2024
- 525 Pages
Global
From €4396EUR$4,799USD£3,736GBP
- Report
- February 2025
- 254 Pages
Global
From €4396EUR$4,799USD£3,736GBP
- Report
- January 2025
- 356 Pages
Global
From €4396EUR$4,799USD£3,736GBP
- Report
- December 2024
- 470 Pages
Global
From €4396EUR$4,799USD£3,736GBP
- Report
- November 2024
- 997 Pages
Global
From €4396EUR$4,799USD£3,736GBP
- Report
- November 2024
- 799 Pages
Global
From €4396EUR$4,799USD£3,736GBP
- Report
- November 2024
- 319 Pages
Global
From €4396EUR$4,799USD£3,736GBP
- Report
- August 2024
- 381 Pages
Global
From €4396EUR$4,799USD£3,736GBP
- Report
- January 2025
- 343 Pages
Global
From €4396EUR$4,799USD£3,736GBP
- Report
- June 2024
- 299 Pages
Global
From €5297EUR$5,985USD£4,350GBP
- Report
- May 2024
- 391 Pages
Global
From €5297EUR$5,985USD£4,350GBP
- Report
- March 2025
- 367 Pages
Global
From €5297EUR$5,985USD£4,350GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more